These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24113443)

  • 1. [Association between multiple myeloma and acute myeloid leukemia secondary to myelodysplastic syndrome].
    Jennane S; Eddou H; Mahtat el M; Konopacki J; Souleau B; Malfuson JV; Foissaud V; de Revel T
    Ann Biol Clin (Paris); 2013; 71(5):581-4. PubMed ID: 24113443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Simultaneous occurrence of acute myeloid leukemia with multilineage dysplasia and multiple myeloma].
    Yanagimoto M; Usuki K; Iijima K; Hirai Y; Iki S; Urabe A
    Rinsho Ketsueki; 2003 Jan; 44(1):19-24. PubMed ID: 12649833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelodysplastic syndrome with del (5q) and JAK2(V617F) mutation transformed to acute myeloid leukaemia with complex karyotype.
    Pich A; Godio L; Riera L; Cavaliere C; Kerim S; Bonello L; Francia di Celle P
    Ann Hematol; 2016 Feb; 95(3):525-7. PubMed ID: 26750119
    [No Abstract]   [Full Text] [Related]  

  • 4. Case report of isochromosome 17q in acute myeloid leukemia with myelodysplasia-related changes after treatment with a hypomethylating agent.
    Sousa JC; Germano RT; Castro CC; Magalhaes SM; Pinheiro RF
    Genet Mol Res; 2012 Aug; 11(3):2045-50. PubMed ID: 22911588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous occurrence of the 5q- syndrome and multiple myeloma.
    Rios R; Sole F; Gascon F
    Clin Lab Haematol; 2000 Feb; 22(1):49-53. PubMed ID: 10762305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression.
    Göhring G; Giagounidis A; Büsche G; Kreipe HH; Zimmermann M; Hellström-Lindberg E; Aul C; Schlegelberger B
    Ann Hematol; 2010 Apr; 89(4):365-74. PubMed ID: 19855965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.
    Sebaa A; Ades L; Baran-Marzack F; Mozziconacci MJ; Penther D; Dobbelstein S; Stamatoullas A; Récher C; Prebet T; Moulessehoul S; Fenaux P; Eclache V
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1086-92. PubMed ID: 22933333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid leukemia cutis in the setting of myelodysplastic syndrome: a crucial dermatological diagnosis.
    Patel LM; Maghari A; Schwartz RA; Kapila R; Morgan AJ; Lambert WC
    Int J Dermatol; 2012 Apr; 51(4):383-8. PubMed ID: 22435424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic abnormalities in acute leukemia complicating melphalan-treated multiple myeloma.
    Rödjer S; Swolin B; Weinfeld A; Westin J
    Cancer Genet Cytogenet; 1990 Aug; 48(1):67-73. PubMed ID: 2372790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disappearing myelodysplastic syndrome-associated hemolytic anemia in leukemic transformation.
    Tabata R; Tabata C; Omori K; Nagai T
    Int Arch Allergy Immunol; 2010; 152(4):407-12. PubMed ID: 20197683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More on polymyalgia rheumatica (PMR) as a paraneoplastic rheumatic syndrome in the elderly (bicytopenia and PMR preceding acute myeloid leukemia).
    Anton E
    J Clin Rheumatol; 2007 Apr; 13(2):114. PubMed ID: 17414547
    [No Abstract]   [Full Text] [Related]  

  • 12. [Myelodysplastic syndromes: multiplicity of the hematologic and clinical aspects].
    Bernasconi C; Lazzarino M; Morra E; Alessandrino EP; Brusamolino E; Bernasconi P; Inverardi D
    Haematologica; 1989 Oct; 74(5 Suppl):110-27. PubMed ID: 2512202
    [No Abstract]   [Full Text] [Related]  

  • 13. Transcriptosome and serum cytokine profiling of an atypical case of myelodysplastic syndrome with progression to acute myelogenous leukemia.
    Mahadevan D; DiMento J; Croce KD; Riley C; George B; Fuchs D; Mathews T; Wilson C; Lobell M
    Am J Hematol; 2006 Oct; 81(10):779-86. PubMed ID: 16838325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression signatures of pediatric myelodysplastic syndromes are associated with risk of evolution into acute myeloid leukemia.
    Bresolin S; Trentin L; Zecca M; Giordan M; Sainati L; Locatelli F; Basso G; te Kronnie G
    Leukemia; 2012 Jul; 26(7):1717-9. PubMed ID: 22411123
    [No Abstract]   [Full Text] [Related]  

  • 15. Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups.
    Gadji M; Adebayo Awe J; Rodrigues P; Kumar R; Houston DS; Klewes L; Dièye TN; Rego EM; Passetto RF; de Oliveira FM; Mai S
    Clin Cancer Res; 2012 Jun; 18(12):3293-304. PubMed ID: 22539801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare tetraploidy with large 5q deletion in acute myeloid leukemia with myelodysplasia-related changes (AML-MRC).
    Jarosova M; Nedomova R; Hubacek J; Holzerova M; Mickova P; Katrincsakova B; Pikalova Z; Papajik T; Indrak K
    Leuk Res; 2012 Apr; 36(4):e68-70. PubMed ID: 22284693
    [No Abstract]   [Full Text] [Related]  

  • 17. Array CGH in human leukemia: from somatics to genetics.
    van der Veken LT; Buijs A
    Cytogenet Genome Res; 2011; 135(3-4):260-70. PubMed ID: 21893961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy-related myelodysplastic syndrome/acute myeloid leukemia with del(7)(q22) in a patient with de novo AML.
    Kim YG; Cho SY; Park TS; Oh SH; Yoon HJ
    Ann Clin Lab Sci; 2011; 41(1):79-83. PubMed ID: 21325260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal evolution in primary 5q-syndrome.
    Wong KF; Chan JK; Chu YC; Kwong YL
    Cancer; 1992 Jul; 70(1):100-3. PubMed ID: 1606529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms.
    Forghieri F; Paolini A; Morselli M; Bigliardi S; Bonacorsi G; Leonardi G; Coluccio V; Maccaferri M; Fantuzzi V; Faglioni L; Colaci E; Soci F; Nasillo V; Messerotti A; Arletti L; Pioli V; Zucchini P; Quadrelli C; Corradini G; Giacobbi F; Vallerini D; Riva G; Barozzi P; Lagreca I; Marasca R; Narni F; Mecucci C; Ottaviani E; Martinelli G; Falini B; Luppi M; Potenza L
    Leuk Lymphoma; 2015; 56(11):3222-6. PubMed ID: 25813079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.